Laxmi Dental Limited (LAXMIDENTL) Fair Value & Analysis
Healthcare · IN · Market cap ₹12.4B
Fair value as of: Jul 3, 2026
From 15 valuation models · updated today
Share price −2.6% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹156.00 – ₹490.68 · fair‑value band ₹67.22 – ₹112.04 · the ₹224.78 price screens above the ₹89.63 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Laxmi Dental Limited (LAXMIDENTL) currently trades at ₹224.78, while our model-based Fair Value estimate is ₹89.63 — implying the stock looks roughly 60.1% overvalued today. We read business quality at 36/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, Laxmi Dental Limited generated revenue of ₹2.8B at a net margin of 10.4%. Revenue grew 21.9% year over year. It earns a return on equity of 12.8%. Net debt stands at ₹46.1M. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Laxmi Dental Limited manufactures and sells dental products in India, the United States, the United Kingdom, and internationally. It offers custom-made crowns, bridges, clear aligners, thermoforming sheets, and aligner related products, and pediatric dental products. The company serves dental clinics, dental companies, and dentist. The company was incorporated in 2004 and is based in Mumbai, India.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Laxmi Dental Limited reported revenue of ₹2.8B in FY2026 versus ₹1.3B in FY2022, a compound +21.0%/yr. Reported net income was ₹290M in FY2026.
Is LAXMIDENTL fairly valued? → Check now
Similar stocks
6 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $422.06 | $165.35 | -61% |
| EssilorLuxottica Société anonyme ESLOF | $192.00 | $126.51 | -34% |
| HOYA Corporation HOCPY | $178.46 | $103.27 | -42% |
| Medline Inc MDLN | $36.54 | $30.66 | -16% |
| Becton, Dickinson and Company BDX | $140.71 | $104.17 | -26% |
| Alcon Inc ALC | $65.18 | $44.21 | -32% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Laxmi Dental Limited (LAXMIDENTL) undervalued?
What is the fair value of LAXMIDENTL?
What is the quality score of LAXMIDENTL?
What is the revenue of Laxmi Dental Limited (LAXMIDENTL)?
What is the net profit margin of LAXMIDENTL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.